We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MorphoSys Initiates Phase 2 Study of Anti-CD19 Antibody MOR208 in B-ALL

News   Apr 29, 2013

 
MorphoSys Initiates Phase 2 Study of Anti-CD19 Antibody MOR208 in B-ALL
 
 
 

RELATED ARTICLES

Having a Heavier First-Born or Shorter Pregnancy May Increase Mother’s Breast Cancer Risk

News

Short first pregnancies and having a heavier first-born child may slightly increase a mother’s risk of breast cancer, a new study has found.

READ MORE

Previously Unknown Role for Basophils in the Lung

News

Basophils, immune cells mainly known in the context of allergy, found to play a crucial role in the development of macrophages in the lung.

READ MORE

Study Identifies Effective Ketamine Doses for Treatment-Resistant Depression

News

Study identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE